SIFALIMUMAB
UNII XOY1YA7RMC

Substance Identification & Data

This profile provides standardized clinical and technical data for Sifalimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XOY1YA7RMC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1006877-41-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XOY1YA7RMC

CAS Registry Number

1006877-41-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIFALIMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C95061

National Cancer Institute reference terminology for clinical and research data.

INN ID

9135

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-130

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sifalimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIFALIMUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON .ALPHA.) (HUMAN MONOCLONAL MEDI-545 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI-545 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERFERON ALPHA SUBTYPES) HUMAN MONOCLONAL MEDI-545 .GAMMA.1 HEAVY CHAIN (219-215')-DISULFIDE WITH HUMAN MONOCLONAL MEDI-545 .KAPPA. LIGHT CHAIN, DIMER (225-225'':228-228'')-BISDISULFIDE

SIFALIMUMAB [INN]

SIFALIMUMAB [USAN]

SIFALIMUMAB [WHO-DD]